GRN and atherosclerosis: In mouse models, genetic deletion of PGRN in an atherogenic background (such as ApoE or LDLr knockout) accelerates atherosclerosis despite a favorable plasma lipid profile, underscoring the importance of PGRN’s local actions in the vessel wall rather than systemic lipid modulation.